Elekta

Medicine and Health/Clinical and Theoretical Areas

Stockholm, Sweden

Description

Elekta is a publicly traded healthcare technology company founded in 1972 and headquartered in Stockholm, Sweden. The company specializes in providing clinical solutions for treating cancer and brain disorders, including radiation therapy equipment and oncology software. With approximately 4,600 employees, Elekta serves a global customer base primarily through B2B engagements, offering advanced medical devices and support for cancer treatment centers worldwide. In the latest fiscal data, the company's revenue reached $18.12 billion. As a key player in the medical technology sector, Elekta continues to focus on innovation in oncology care and neuro-oncology treatments.

Experteer Insights

Locations 23

Experteer Briefing

Company Trajectory

Founded in 1972 in Stockholm, Sweden, Elekta emerged with the goal of commercializing the Leksell Stereotactic System and Gamma Knife, which were pioneering neurosurgical tools. Over the decades, the company expanded from its original focus into a global leader in clinical solutions for cancer and brain disorder treatment, consistently evolving its offerings and extending its reach. Elekta has achieved significant milestones, such as market expansions and the launch of subsidiaries, while staying at the forefront of neurosurgical and radiation therapy innovation.

Financial Setup

Elekta is a publicly traded company employing more than 4,600 people worldwide. It operates with a B2B model, serving hospitals and cancer treatment centers internationally. The company’s business revolves around the manufacture and provision of advanced radiation therapy equipment and oncology software, adapting its revenue generation model to technological advancements and global market needs. This solid employee base and international presence underscore Elekta’s standing as a major industry player.

Development & Outlook

Recent developments at Elekta include the ongoing advancement of precision radiation therapy devices and oncology software, with flagship products such as Elekta Unity and Elekta Versa HD linear accelerators, the Leksell Gamma Knife, and the MOSAIQ oncology information system. The company holds a broad patent portfolio reflecting significant R&D investment in neurosurgical and radiation technologies. Elekta has demonstrated a strong commitment to sustainability by issuing sustainability-linked bonds to enhance cancer care in underserved regions, and it established the Elekta Foundation to improve global cancer care access. Adhering to rigorous environmental protocols, Elekta continues to drive innovation, sustainability, and societal impact as it shapes the future of cancer care.